Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein (original) (raw)

References

  1. Shepard, C.W., Simard, E.P., Finelli, L., Fiore, A.E. & Bell, B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol. Rev. 28, 112–125 (2006).
    Article Google Scholar
  2. Engelke, M. et al. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology 43, 750–760 (2006).
    Article CAS Google Scholar
  3. Glebe, D. et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology 129, 234–245 (2005).
    Article CAS Google Scholar
  4. Gripon, P. et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. USA 99, 15655–15660 (2002).
    Article CAS Google Scholar
  5. Gripon, P., Cannie, I. & Urban, S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J. Virol. 79, 1613–1622 (2005).
    Article CAS Google Scholar
  6. Dandri, M. et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 33, 981–988 (2001).
    Article CAS Google Scholar
  7. Dandri, M. et al. Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes. J. Hepatol. 42, 54–60 (2005).
    Article CAS Google Scholar
  8. Root, M.J. & Steger, H.K. HIV-1 gp41 as a target for viral entry inhibition. Curr. Pharm. Des. 10, 1805–1825 (2004).
    Article CAS Google Scholar
  9. Chan, H.L. & Sung, J.J. Hepatocellular carcinoma and hepatitis B virus. Semin. Liver Dis. 26, 153–161 (2006).
    Article CAS Google Scholar
  10. Zoulim, F. Antiviral therapy of chronic hepatitis B. Antiviral Res. 71, 206–215 (2006).
    Article CAS Google Scholar
  11. Seeger, C. & Mason, W.S. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64, 51–68 (2000).
    Article CAS Google Scholar
  12. Bruss, V. Hepatitis B virus morphogenesis. World J. Gastroenterol. 13, 65–73 (2007).
    Article CAS Google Scholar
  13. Gripon, P., Le, S.J., Rumin, S. & Guguen-Guillouzo, C. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 213, 292–299 (1995).
    Article CAS Google Scholar
  14. LeSeyec, J., Chouteau, P., Cannie, I., Guguen-Guillouzo, C. & Gripon, P. Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J. Virol. 73, 2052–2057 (1999).
    CAS Google Scholar
  15. Glebe, D. & Urban, S. Viral and cellular determinants involved in hepadnaviral entry. World J. Gastroenterol. 13, 22–38 (2007).
    Article CAS Google Scholar
  16. Dandri, M., Lutgehetmann, M., Volz, T. & Petersen, J. Small animal model systems for studying hepatitis B virus replication and pathogenesis. Semin. Liver Dis. 26, 181–191 (2006).
    Article CAS Google Scholar
  17. Sandgren, E.P. et al. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 66, 245–256 (1991).
    Article CAS Google Scholar
  18. Schmitz, J., Ohme, M. & Zischler, H. The complete mitochondrial genome of Tupaia belangeri and the phylogenetic affiliation of scandentia to other eutherian orders. Mol. Biol. Evol. 17, 1334–1343 (2000).
    Article CAS Google Scholar
  19. Kock, J. et al. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J. Virol. 75, 5084–5089 (2001).
    Article CAS Google Scholar
  20. Lanford, R.E., Chavez, D., Brasky, K.M., Burns, R.B. III & Rico-Hesse, R. Isolation of a hepadnavirus from the woolly monkey, a New World primate. Proc. Natl. Acad. Sci. USA 95, 5757–5761 (1998).
    Article CAS Google Scholar
  21. Urban, S. & Gripon, P. Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein. J. Virol. 76, 1986–1990 (2002).
    Article CAS Google Scholar
  22. Volz, T. et al. Impaired intrahepatic Hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. Gastroenterology 133, 843–852 (2007).
    Article CAS Google Scholar
  23. Freireich, E.J., Gehan, E.A., Rall, D.P., Schmidt, L.H. & Skipper, H.E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep. 50, 219–244 (1966).
    CAS PubMed Google Scholar
  24. Locarnini, S. et al. Management of antiviral resistance in patients with chronic hepatitis B. Antivir. Ther. 9, 679–693 (2004).
    CAS PubMed Google Scholar
  25. Barrera, A., Guerra, B., Notvall, L. & Lanford, R.E. Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition. J. Virol. 79, 9786–9798 (2005).
    Article CAS Google Scholar
  26. Dandri, M. & Petersen, J. Hepatitis B virus cccDNA clearance: killing for curing? Hepatology 42, 1453–1455 (2005).
    Article Google Scholar
  27. Taylor, J.M. Hepatitis delta virus. Virology 344, 71–76 (2006).
    Article CAS Google Scholar
  28. Glebe, D. Attachment sites and neutralising epitopes of hepatitis B virus. Minerva Gastroenterol. Dietol. 52, 3–21 (2006).
    CAS PubMed Google Scholar
  29. Werle-Lapostolle, B. et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126, 1750–1758 (2004).
    Article CAS Google Scholar
  30. Schulze, A., Gripon, P. & Urban, S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 46, 1759–1768 (2007).
    Article CAS Google Scholar

Download references